View drug registration information details.
Items | Registration information |
ID | 345 |
No | 345 |
Brand Name | CRIZOCARE |
Ingredients | CRIZOTONIB 250 MG |
Dosage Form | CAPSULE |
Primary Packaging | BOTTLE |
Storage | STORE BELOW 30C |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 60'S/BOTTLE |
Dispensing Category | Prescription only |
ATC Classification | |
Pharmaceutical Class | ANTINEOPLASTIC |
Indications | FIRST LINE TREATMENT OF ADULTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE ADVANCED NON SMALL CELL LUNG CANCER, TREATMENT OF ADULTS WITH PREVIOUSLY TREATED ANAPLASTIC LYMPHOMA KINASE-POSITIVE ADVANCED NON SMALL CELL LUNG CANCER, TREATMENT OF ADULT WITH ROS1-POSITIVE ADVANCED NON SMALL CELL LUNG CANCER |
Contraindications | N/A |
Side Effects | N/A |
Unit Price | |
EDL |
No |
Description | CAPSULE SIZE 0, RED CAPSULE CAP AND WHITE CAPSULE BODY |
Note | |
License Owner | BOTEN ELEMENTO PHARMA FACTORY |
Manufacturer | BOTEN ELEMENTO PHARMA FACTORY |
Country | LAO PDR |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | - |
FDD Registration No | 03 L 0847/21 |
FDD Registration Date | 2024-08-07 |
Expiry Date | 2027-08-06 |
Back to drug list
|